Robert Conley is a distinguished scholar at Eli Lilly and Company, where they serve as a Development Leader in Neuroscience. With a primary interest in developing and approving new treatments for serious illnesses, Conley has a strong background in psychiatry. They previously held positions as a Professor of Psychiatry and Pharmacy Science at the University of Maryland, Baltimore from 1989 to 2007, and as an Assistant Professor at the University of Pittsburgh School of Medicine from 1985 to 1989. Conley earned an MD from the University of Maryland School of Medicine and a BA from The Johns Hopkins University.
This person is not in any teams
This person is not in any offices